Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

China flag China · Delayed Price · Currency is CNY
23.27
+0.11 (0.47%)
Apr 28, 2026, 3:04 PM CST
Market Cap22.38B +29.7%
Revenue (ttm)1.17B -11.7%
Net Income31.83M -45.9%
EPS0.04 -40.8%
Shares Out966.49M
PE Ratio703.17
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,192,776
Average Volume19,509,078
Open22.97
Previous Close23.16
Day's Range22.90 - 23.82
52-Week Range16.83 - 30.20
Beta0.45
RSI60.00
Earnings DateApr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers... [Read more]

Sector Healthcare
Founded 1990
Employees 1,480
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000766
Full Company Profile

Financial Performance

In 2025, SHE:000766's revenue was 1.17 billion, a decrease of -11.54% compared to the previous year's 1.32 billion. Earnings were 34.29 million, a decrease of -39.25%.

Financial Statements